The new blood test detects the autoantibodies produced in the body in response to the melanoma. Scientists at the Edith Cowan University (ECU), Australia, have …
A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer (NSCLC), under a …
The arrival of the European Medicines Agency in Amsterdam next year will be a major boost for the Netherlands’ own drugs testing sector, and moves …
Proteomics International is engaged with potential partners to bring PromarkerD to market in mainland USA, Mexico, Japan, Australia, China and Europe. MedTech pioneer Proteomics International …
Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein biomarker panel in the blood. …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
